Literature DB >> 32489036

[Advances in studies on chemical compositions of Alismatis Rhizoma and their biological activities].

Shan-Shan Liu1, Jie Guo2, Zong-Ai Li1, Shuang-Shuang Tian1, Jing-Jing Zhu1, Li-Hua Yan1, Zhi-Min Wang1, Lu Gao3.   

Abstract

Alismatis Rhizoma is a traditional Chinese medicine, which was widely used in clinical prescriptions and proprietary Chinese medicine. Over 220 compounds have been isolated from it, including triterpenoids, sesquiterpenoids, diterpenoids, polysaccharides, nitrogen compounds, phenylpropanoids, flavones and sterides. The pharmacological studies show that Alismatis Rhizoma exhibits diuretic, anti-urolithiatic, anti-hyperlipidemia, antidiabetics, antitumor, antioxidative, anti-inflammatory, anti-complementary activities, etc. In this review, the chemical compositions and its pharmacological activities of Alismatis Rhizoma in recent 50 years were summarized. The authors hope to provide references for further study, development and utilization of Alismatis Rhizoma.

Entities:  

Keywords:  Alismatis Rhizoma; biological activities; chemical compositions; sesquiterpenoids; triterpenoids

Year:  2020        PMID: 32489036     DOI: 10.19540/j.cnki.cjcmm.20190616.201

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  3 in total

Review 1.  Efficacy of Longdan Xiegan Decoction on the Treatment of Eczema: A Systematic Review and Meta-Analysis.

Authors:  Ziteng Hu; Lidong Gao; Chengxian Li; Alberto Cucco; Shang Wang; Weiling Yuan; Fan Zhang; Shuai Kang; Min Wang
Journal:  Evid Based Complement Alternat Med       Date:  2021-02-18       Impact factor: 2.629

2.  Efficacy and safety of zhibitai in the treatment of hyperlipidemia: A systematic review and meta-analysis.

Authors:  Chunyang Wang; Wentai Pang; Xuechen Du; Jiani Zhai; Mengyuan Zhong; Ming Zhuang; Jiali An; Lujia Cao; Li Zhang; Wenke Zheng; Junhua Zhang
Journal:  Front Pharmacol       Date:  2022-09-02       Impact factor: 5.988

Review 3.  Pharmacological Properties and Molecular Targets of Alisol Triterpenoids from Alismatis Rhizoma.

Authors:  Christian Bailly
Journal:  Biomedicines       Date:  2022-08-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.